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Mouthwash reduces oral gonorrhoea
Gargling daily with the antiseptic mouthwash, Listerine, may control 
oral gonorrhoea, according to a study in Australia. Researchers in 
Melbourne looked at 196 gay or bisexual men positive for Neisseria 
gonorrhoea, who presented at the Melbourne Sexual Health Centre for 
treatment. Of the 58 men who tested positive for oral gonorrhoea, 33 
were randomly assigned to gargle with Listerine Cool Mint and 25 with 
a saline solution. 
After rinsing and gargling for 1 minute, the proportion of viable gon-
orrhoea in the throat was 52% in the men using Listerine, compared with 
84% in those using saline (p=0.013). Five minutes after gargling, men in 
the Listerine group were 80% less likely to test positive for gonorrhoea in 
their throat than the men using the saline solution.
The researchers also tested different dilutions of Listerine in a labora-
tory setting. Listerine, at dilutions of up to 1 in 4 and applied for 1 min-
ute, considerably reduced the number of N. gonorrhoea on the culture 
plates, whereas the saline solution had no effect.
The effects may be short lived as the follow-up time was short, even 
though the laboratory evidence of an inhibitory effect of Listerine is 
encouraging. 
Chow  E,  Howden  B,  Walker  S,  et al. Antiseptic mouthwash against pharyngeal Neisseria gonorrhoeae: A 
randomised controlled trial and an in vitro study. Sex Transm Infect 2016;92:A2. http://dx.doi.org/10.1136/
sextrans-2016-052718.4
Living near major roads increases risk 
of dementia
Living next to a major road slightly increases the risk of dementia, but 
not of Parkinson’s disease or multiple sclerosis. These are the results of 
a population-based cohort study, recently published in the Lancet. Two 
cohorts of people were studied to assess the link between living near 
a busy road and incident neurodegenerative disease. The first cohort, 
studied for the onset of multiple sclerosis, included all 4.4 million adults 
aged 20 - 50 in Ontario, Canada, on 1 April 2001. The second, studied for 
the risk of dementia and Parkinson’s disease, included all the older adults 
(2.2 million aged 55 - 85 years) living in the same area. 
Results showed that people living <50  m from a busy road had 
a 7% higher risk of new-onset dementia than those living 300  m 
away, after adjusting for age, sex, comorbidities and education. 
This increased risk was even higher for people living <50  m from a 
busy road and for those who had always lived next to major traffic. 
It would seem that this risk may operate through exposure to nitrogen 
dioxide (NO2) and fine particulate matter (PM2.5). Adjusting for these 
two pollutants attenuated the association with proximity to a roadway.
Chen J, Kwong JC, Copes R, et al. Living near major roads and the incidence of dementia, Parkinson’s disease 
and multiple sclerosis: A population-based cohort study. Lancet 2017. http://dx.doi.org/10.1016/S0140-
6736(16)32399-6 (published online 4 January 2017).
‘Weekend warriors’ as fit as those who 
exercise through the week
The World Health Organization and US Department of Health and 
Human Services recommend at least 150 minutes a week of mode rate-
intensity aerobic activity or 75 minutes a week of vigorous activity spread 
through the week. However, many people concentrate their exercise 
over the weekend because of time constraints during the week. There 
has been little research on the effects of the ‘weekend warrior’ physical 
activity pattern, until recently. Now, a study published in JAMA Internal 
Medicine suggests that compressing this amount of physical activity into 
a weekend rather than spreading it through the week may be enough to 
reduce all-cause, cardiovascular and cancer mortality.
The research, from Loughborough University, UK, was carried out 
on a pooled analysis of 63 591 adults from 11 cohorts of respondents 
to English and Scottish health surveys. Data from 1994 to 2008 were 
collected, and the mean age of participants was 58.6 years. 
Participants reported the amount of exercise carried out in the 
previous 4 weeks and were divided into inactive; insufficiently active, 
if they did less than the recommended amount of exercise; weekend 
warrior, if they did the recommended amount of exercise in 1 or 2 
sessions; or regularly active, if the exercise was spread across 3 or more 
sessions. 
The researchers found 8  802 deaths from all causes, 2  780 from 
cardiovascular disease, and 2 526 from cancer during 561 159 person-
years of follow-up.
The risk of death from all causes was about 30% lower in weekend 
warriors than in inactive adults. When compared with inactive adults, 
the risk of cardiovascular death in weekend warriors was 40% lower and 
the risk of death from cancer was 18% lower.
However, the risk of all-cause mortality was still lowest among 
the regularly active adults, although the authors concluded that ‘The 
weekend warrior and other physical activity patterns characterised by 
one or two sessions per week of moderate or vigorous intensity physical 
activity may be sufficient to reduce risks for all cause, cardiovascular and 
cancer mortality regardless of adherence to prevailing physical activity 
guidelines’.
O’Donovan G, Lee I, Hamer M, et al. Association of ‘weekend warrior’ and other leisure time physical activity 
patterns with risks for all-cause, cardiovascular disease and cancer mortality. JAMA Intern Med 2017. http://
dx.doi.org/10.1001/jamainternmed.2016.8014 (published online 9 January 2017).
Elderly patients do better with female 
doctor
Elderly hospital patients have a lower 30-day mortality and readmission 
rate if treated by female doctors, according to a study published in JAMA 
Internal Medicine. Previous studies have found that men and women 
practise medicine differently; for example, women are more likely to 
adhere to clinical practice guidelines and offer preventive care more 
often. However, it is not known whether these differences affect clinical 
outcomes. 
In this new study by Tsugawa et al. from Harvard T H Chan School 
of Public Health, Cambridge, Massachusetts, 1.6 million admissions of 
patients aged >65 years for medical conditions, treated by general physi-
cians, were analysed. After adjusting for many factors, such as type and 
severity of the patients’ medical conditions, patient and physician charac-
teristics, and hospital size and type, researchers found that those treated 
by a female physician had a lower 30-day mortality and readmission rate. 
Tsugawa  Y,  Jena  AB,  Figueroa  JF,  Orav  EJ,  Blumenthal  DM,  Jha  AK. Comparison of hospital mortality and 
readmission rates for Medicare patients treated by male vs female physicians. JAMA Intern Med 2016. http://
dx.doi.org/10.1001/jamainternmed.2016.7875 (published online 19 December 2016).
Use inhaled corticosteroids regardless of 
asthma symptom frequency
Low-dose inhaled corticosteroids (ICS) are highly effective for redu cing 
asthma exacerbations and mortality, but conventionally ICS treatment 
is recommended for patients who have symptoms on >2 days a week, 
although there is little evidence to support this recommendation. This 
study, published in the Lancet, assessed the validity of the previous 
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symptom-based cut-off by establishing whether there was a differ-
ential response to budesonide v. placebo for severe asthma exacerba-
tions, lung function, and asthma symptom control across subgroups 
identified by baseline asthma symptom frequency. 
They used a post-hoc analysis of the 3-year inhaled Steroid Treat-
ment As Regular Therapy (START) study, done in 32 countries, 
with clinic visits every 3 months. Patients (aged 4 - 66 years) with 
mild asthma diagnosed within the previous 2 years and no previous 
regular use of corticosteroids were randomised to receive once daily, 
inhaled budesonide 400 μg (those aged <11 years 200 μg) or placebo. 
They found that in mild recent-onset asthma, once daily, low-
dose budesonide decreases severe asthma-related risk, reduces lung 
function decline, and improves symptom control similarly across all 
symptom subgroups. The results do not support restriction of inhaled 
corticosteroids to patients with symptoms on >2 days per week and 
suggest that treatment recommendations for mild asthma should 
consider both risk reduction and symptoms.
Reddel HK, Busse WW, Pedersen S, et al. Should recommendations about starting inhaled corticosteroid 
treatment for mild asthma be based on symptom frequency: A post-hoc efficacy analysis of the START 
study. Lancet 2017;389(10065):157-166. http://dx.doi.org/10.1016/S0140-6736(16)31399-X
Bridget Farham
Editor
ugqirha@iafrica.com
